ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Dabigatran Sandoz 150 mg, Hartkapseln - 60
68658003 Sandoz Pharmaceuticals AG
Dabigatran Sandoz 150 mg, Hartkapseln07.06.2023
Generic07.06.2023
Dabigatran Etexilate (B01AE07) 
WHO-DDD06.06.2028
06.03.20.60
06.03. 
B  
Yes 
IP 
40.97No
    
10 %60.95
7680686580039Synthetika
 ● 
Composition
dabigatranum etexilatum 150 mg ut dabigatrani etexilati mesilas, acidum tartaricum, hypromellosum, talcum, hydroxypropylcellulosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: hypromellosum, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.9 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Dabigatranum Etexilatum150 mg
BAG: Active AgentDose
Dabigatranum Etexilatum150 mg
 
Inactive agents additional_information
(Nigrum)  
Tartaric Acid  
Carmellosum Natricum Conexum  
E 171 color.
E 172 color.
Hydroxypropylcellulosum  
Hypromellosum Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Propylenglycol  
Talcum  
 
Source
Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home